Q4 2023 · 13F-HR
Integral Health Asset Management, LLCholdings as filed
Filed 2024-02-14 · accession 0001172661-24-001039
$734.3M
Reported value
69
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 23282W605 | CYTK | CYTOKINETICS INC | $33.4M | 4.55% | 400,000 | CALL | SOLE |
| 931427108 | WFC | WALGREENS BOOTS ALLIANCE INC | $28.7M | 3.91% | 1,100,000 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $26.4M | 3.60% | 350,000 | Common | SOLE |
| 00287Y109 | ABBV | ABBVIE INC | $26.3M | 3.59% | 170,000 | Common | SOLE |
| 66987V109 | NVS | NOVARTIS AG | $22.7M | 3.09% | 225,000 | Common | SOLE |
| 75886F107 | REGN | REGENERON PHARMACEUTICALS | $22.0M | 2.99% | 25,000 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $21.7M | 2.95% | 375,000 | Common | SOLE |
| 80105N105 | SNY | SANOFI | $19.9M | 2.71% | 400,000 | Common | SOLE |
| 879369106 | TFX | TELEFLEX INCORPORATED | $17.5M | 2.38% | 70,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $16.7M | 2.27% | 200,000 | Common | SOLE |
| 29261A100 | EHC | ENCOMPASS HEALTH CORP | $16.7M | 2.27% | 250,000 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $16.3M | 2.22% | 28,000 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $15.5M | 2.11% | 125,000 | Common | SOLE |
| 159864107 | CRL | CHARLES RIV LABS INTL INC | $15.4M | 2.09% | 65,000 | Common | SOLE |
| 03073E105 | COR | CENCORA INC | $14.4M | 1.96% | 70,000 | Common | SOLE |
| 632307104 | NTRA | NATERA INC | $14.1M | 1.92% | 225,000 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $13.5M | 1.84% | 40,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $13.3M | 1.81% | 220,000 | Common | SOLE |
| 216648402 | — | COOPER COS INC | $13.2M | 1.80% | 35,000 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $12.9M | 1.76% | 140,000 | Common | SOLE |
| 46116X101 | ITCIEUR | INTRA-CELLULAR THERAPIES INC | $12.5M | 1.71% | 175,000 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $12.2M | 1.66% | 60,000 | Common | SOLE |
| 98956P102 | ZBH | ZIMMER BIOMET HOLDINGS INC | $12.2M | 1.66% | 100,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $11.9M | 1.61% | 90,000 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $11.8M | 1.61% | 520,000 | Common | SOLE |
| 50540R409 | LSI | LABORATORY CORP AMER HLDGS | $11.4M | 1.55% | 50,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $10.8M | 1.48% | 350,000 | Common | SOLE |
| 913903100 | UHS | UNIVERSAL HLTH SVCS INC | $10.7M | 1.45% | 70,000 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $10.5M | 1.44% | 85,000 | Common | SOLE |
| 70975L107 | PEN | PENUMBRA INC | $10.1M | 1.37% | 40,000 | Common | SOLE |
| G4705A100 | ICLR | ICON PLC | $9.9M | 1.35% | 35,000 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $9.9M | 1.35% | 55,000 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $9.9M | 1.35% | 120,000 | Common | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $9.6M | 1.31% | 130,000 | Common | SOLE |
| 036752103 | ELV | ELEVANCE HEALTH INC | $9.4M | 1.28% | 20,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $9.3M | 1.27% | 500,000 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $8.9M | 1.21% | 160,000 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $8.6M | 1.17% | 45,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $8.3M | 1.14% | 100,000 | PUT | SOLE |
| 30050B101 | EVH | EVOLENT HEALTH INC | $8.3M | 1.12% | 250,000 | Common | SOLE |
| 016255101 | ALGN | ALIGN TECHNOLOGY INC | $8.2M | 1.12% | 30,000 | Common | SOLE |
| 35104E100 | FDMT | 4D MOLECULAR THERAPEUTICS IN | $7.6M | 1.03% | 375,000 | Common | SOLE |
| 28414H103 | ELAN | ELANCO ANIMAL HEALTH INC | $7.5M | 1.01% | 500,000 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $7.3M | 1.00% | 100,000 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $7.2M | 0.98% | 175,000 | Common | SOLE |
| 436440101 | HO1 | HOLOGIC INC | $7.1M | 0.97% | 100,000 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $7.1M | 0.97% | 200,000 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $7.0M | 0.95% | 50,000 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $6.9M | 0.94% | 249,000 | Common | SOLE |
| 825704109 | SIBN | SI-BONE INC | $6.6M | 0.90% | 315,000 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $6.6M | 0.90% | 600,000 | Common | SOLE |
| 45332Y109 | NARIUSD | INARI MED INC | $6.5M | 0.88% | 100,000 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $5.8M | 0.79% | 325,000 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $5.7M | 0.78% | 200,000 | Common | SOLE |
| 54300N103 | — | LONGBOARD PHARMACEUTICALS IN | $5.4M | 0.74% | 900,000 | Common | SOLE |
| 05352A100 | AVTR | AVANTOR INC | $4.6M | 0.62% | 200,000 | Common | SOLE |
| 78667J108 | SG7 | SAGE THERAPEUTICS INC | $4.3M | 0.59% | 200,000 | Common | SOLE |
| 556099109 | MGNX | MACROGENICS INC | $4.3M | 0.59% | 450,000 | Common | SOLE |
| 00857U107 | — | AGILON HEALTH INC | $4.1M | 0.56% | 325,000 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $4.1M | 0.55% | 130,000 | Common | SOLE |
| 761330109 | RVNCEUR | REVANCE THERAPEUTICS INC | $4.0M | 0.54% | 450,000 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $3.8M | 0.52% | 250,000 | Common | SOLE |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $3.4M | 0.46% | 900,000 | Common | SOLE |
| 703395103 | PDCOEUR | PATTERSON COS INC | $2.8M | 0.39% | 100,000 | Common | SOLE |
| 68622V106 | OGN | ORGANON & CO | $2.2M | 0.29% | 150,000 | Common | SOLE |
| 87918A105 | TDOC | TELADOC HEALTH INC | $2.2M | 0.29% | 100,000 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $2.0M | 0.28% | 100,000 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $1.9M | 0.26% | 100,000 | Common | SOLE |
| 92332V107 | VTYXUSD | VENTYX BIOSCIENCES INC | $1.2M | 0.17% | 500,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.